Works matching AU Schäfer, Niklas


Results: 77
    1
    2
    3
    4
    5
    6

    Impact of patient nationality on the severity of early side effects after radiotherapy.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 9, p. 5573, doi. 10.1007/s00432-022-04505-0
    By:
    • Köksal, Mümtaz;
    • Streppel, Romy;
    • Hauser, Stefan;
    • Abramian, Alina;
    • Kaiser, Christina;
    • Gonzalez-Carmona, Maria;
    • Feldmann, Georg;
    • Schäfer, Niklas;
    • Koob, Sebastian;
    • Banat, Mohammed;
    • Hamed, Motaz;
    • Giordano, Frank A.;
    • Schmeel, Leonard C.
    Publication type:
    Article
    7

    MicroRNA-profiling of miR-371~373- and miR-302/367-clusters in serum and cerebrospinal fluid identify patients with intracranial germ cell tumors.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 791, doi. 10.1007/s00432-022-03915-4
    By:
    • Schönberger, Stefan;
    • Mohseni, Mahsa Mir;
    • Ellinger, Jörg;
    • Tran, Giao Vu Quynh;
    • Becker, Martina;
    • Claviez, Alexander;
    • Classen, Carl-Friedrich;
    • Hermes, Barbara;
    • Driever, Pablo Hernáiz;
    • Jorch, Norbert;
    • Lauten, Melchior;
    • Mehlitz, Marcus;
    • Schäfer, Niklas;
    • Scheer-Preiss, Johanna;
    • Schneider, Dominik T.;
    • Troeger, Anja;
    • Calaminus, Gabriele;
    • Dilloo, Dagmar
    Publication type:
    Article
    8

    Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastoma.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 3, p. 787, doi. 10.1007/s00432-019-03106-8
    By:
    • Lazaridis, Lazaros;
    • Schäfer, Niklas;
    • Teuber-Hanselmann, Sarah;
    • Blau, Tobias;
    • Schmidt, Teresa;
    • Oster, Christoph;
    • Weller, Johannes;
    • Tzaridis, Theophilos;
    • Pierscianek, Daniela;
    • Keyvani, Kathy;
    • Kleinschnitz, Christoph;
    • Stuschke, Martin;
    • Scheffler, Björn;
    • Deuschl, Cornelius;
    • Sure, Ulrich;
    • Herrlinger, Ulrich;
    • Kebir, Sied;
    • Glas, Martin
    Publication type:
    Article
    9

    Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 8, p. 1581, doi. 10.1007/s00432-018-2671-z
    By:
    • Schaub, Christina;
    • Kebir, Sied;
    • Junold, Nina;
    • Hattingen, Elke;
    • Schäfer, Niklas;
    • Steinbach, Joachim P.;
    • Weyerbrock, Astrid;
    • Hau, Peter;
    • Goldbrunner, Roland;
    • Niessen, Michael;
    • Mack, Frederic;
    • Stuplich, Moritz;
    • Tzaridis, Theophilos;
    • Bähr, Oliver;
    • Kortmann, Rolf-Dieter;
    • Schlegel, Uwe;
    • Schmidt-Graf, Friederike;
    • Rohde, Veit;
    • Braun, Christian;
    • Hänel, Mathias
    Publication type:
    Article
    10
    11
    12

    Phase I trial of dovitinib (TKI258) in recurrent glioblastoma.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 7, p. 1581, doi. 10.1007/s00432-016-2161-0
    By:
    • Schäfer, Niklas;
    • Gielen, Gerrit;
    • Kebir, Sied;
    • Wieland, Anja;
    • Till, Andreas;
    • Mack, Frederic;
    • Schaub, Christina;
    • Tzaridis, Theophilos;
    • Reinartz, Roman;
    • Niessen, Michael;
    • Fimmers, Rolf;
    • Simon, Matthias;
    • Coch, Christoph;
    • Fuhrmann, Christine;
    • Herrlinger, Ulrich;
    • Scheffler, Björn;
    • Glas, Martin
    Publication type:
    Article
    13
    14
    15
    16

    Perioperative red blood cell transfusion is associated with poor functional outcome and overall survival in patients with newly diagnosed glioblastoma.

    Published in:
    Neurosurgical Review, 2022, v. 45, n. 2, p. 1327, doi. 10.1007/s10143-021-01633-y
    By:
    • Schneider, Matthias;
    • Schäfer, Niklas;
    • Potthoff, Anna-Laura;
    • Weinhold, Leonie;
    • Eichhorn, Lars;
    • Weller, Johannes;
    • Scharnböck, Elisa;
    • Schaub, Christina;
    • Heimann, Muriel;
    • Güresir, Erdem;
    • Lehmann, Felix;
    • Vatter, Hartmut;
    • Herrlinger, Ulrich;
    • Schuss, Patrick
    Publication type:
    Article
    17

    Tumor-associated epilepsy in patients with brain metastases: necrosis-to-tumor ratio forecasts postoperative seizure freedom.

    Published in:
    Neurosurgical Review, 2022, v. 45, n. 1, p. 545, doi. 10.1007/s10143-021-01560-y
    By:
    • Bahna, Majd;
    • Heimann, Muriel;
    • Bode, Christian;
    • Borger, Valeri;
    • Eichhorn, Lars;
    • Güresir, Erdem;
    • Hamed, Motaz;
    • Herrlinger, Ulrich;
    • Ko, Yon-Dschun;
    • Lehmann, Felix;
    • Potthoff, Anna-Laura;
    • Radbruch, Alexander;
    • Schaub, Christina;
    • Surges, Rainer;
    • Weller, Johannes;
    • Vatter, Hartmut;
    • Schäfer, Niklas;
    • Schneider, Matthias;
    • Schuss, Patrick
    Publication type:
    Article
    18
    19
    20
    21

    Kleine Mondfinsternis.

    Published in:
    Mitteilungen der DMV, 2023, v. 31, n. 3, p. 204, doi. 10.1515/dmvm-2023-0065
    By:
    • Lutz-Westphal, Brigitte;
    • Schäfer, Niklas
    Publication type:
    Article
    22

    Cost Effectiveness of <sup>18</sup>F-FET PET for Early Treatment Response Assessment in Glioma Patients After Adjuvant Temozolomide Chemotherapy.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 11, p. 1677, doi. 10.2967/jnumed.122.263790
    By:
    • Rosen, Jurij;
    • Ceccon, Garry;
    • Bauer, Elena K.;
    • Werner, Jan-Michael;
    • Tscherpel, Caroline;
    • Dunkl, Veronika;
    • Rapp, Marion;
    • Sabel, Michael;
    • Herrlinger, Ulrich;
    • Heinzel, Alexander;
    • Schäfer, Niklas;
    • Ruge, Maximilian;
    • Goldbrunner, Roland;
    • Stoffels, Gabriele;
    • Kabbasch, Christoph;
    • Fink, Gereon R.;
    • Langen, Karl-Josef;
    • Galldiks, Norbert
    Publication type:
    Article
    23

    Cost-effectiveness of <sup>18</sup>F-FET PET for early treatment response assessment in glioma patients following adjuvant temozolomide chemotherapy.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.263790
    By:
    • Rosen, Jurij;
    • Ceccon, Garry;
    • Bauer, Elena K.;
    • Werner, Jan-Michael;
    • Tscherpel, Caroline;
    • Dunkl, Veronika;
    • Rapp, Marion;
    • Sabel, Michael;
    • Herrlinger, Ulrich;
    • Heinzel, Alexander;
    • Schäfer, Niklas;
    • Ruge, Maximilian;
    • Goldbrunner, Roland;
    • Stoffels, Gabriele;
    • Kabbasch, Christoph;
    • Fink, Gereon R.;
    • Langen, Karl-Josef;
    • Galldiks, Norbert
    Publication type:
    Article
    24

    Cost-effectiveness of 18F-FET PET for early treatment response assessment in glioma patients following adjuvant temozolomide chemotherapy.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.122.263790
    By:
    • Rosen, Jurij;
    • Ceccon, Garry;
    • Bauer, Elena K.;
    • Werner, Jan-Michael;
    • Tscherpel, Caroline;
    • Dunkl, Veronika;
    • Rapp, Marion;
    • Sabel, Michael;
    • Herrlinger, Ulrich;
    • Heinzel, Alexander;
    • Schäfer, Niklas;
    • Ruge, Maximilian;
    • Goldbrunner, Roland;
    • Stoffels, Gabriele;
    • Kabbasch, Christoph;
    • Fink, Gereon R.;
    • Langen, Karl-Josef;
    • Galldiks, Norbert
    Publication type:
    Article
    25

    Cost-effectiveness of <sup>18</sup>F-FET PET for early treatment response assessment in glioma patients following adjuvant temozolomide chemotherapy.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.122.263790
    By:
    • Rosen, Jurij;
    • Ceccon, Garry;
    • Bauer, Elena K.;
    • Werner, Jan-Michael;
    • Tscherpel, Caroline;
    • Dunkl, Veronika;
    • Rapp, Marion;
    • Sabel, Michael;
    • Herrlinger, Ulrich;
    • Heinzel, Alexander;
    • Schäfer, Niklas;
    • Ruge, Maximilian;
    • Goldbrunner, Roland;
    • Stoffels, Gabriele;
    • Kabbasch, Christoph;
    • Fink, Gereon R.;
    • Langen, Karl-Josef;
    • Galldiks, Norbert
    Publication type:
    Article
    26

    Cost-effectiveness of <sup>18</sup>F-FET PET for early treatment response assessment in glioma patients following adjuvant temozolomide chemotherapy.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.263790
    By:
    • Rosen, Jurij;
    • Ceccon, Garry;
    • Bauer, Elena K.;
    • Werner, Jan-Michael;
    • Tscherpel, Caroline;
    • Dunkl, Veronika;
    • Rapp, Marion;
    • Sabel, Michael;
    • Herrlinger, Ulrich;
    • Heinzel, Alexander;
    • Schäfer, Niklas;
    • Ruge, Maximilian;
    • Goldbrunner, Roland;
    • Stoffels, Gabriele;
    • Kabbasch, Christoph;
    • Fink, Gereon R.;
    • Langen, Karl-Josef;
    • Galldiks, Norbert
    Publication type:
    Article
    27

    Cost-effectiveness of <sup>18</sup>F-FET PET for early treatment response assessment in glioma patients following adjuvant temozolomide chemotherapy.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 5, p. 1, doi. 10.2967/jnumed.122.263790
    By:
    • Rosen, Jurij;
    • Ceccon, Garry;
    • Bauer, Elena K.;
    • Werner, Jan-Michael;
    • Tscherpel, Caroline;
    • Dunkl, Veronika;
    • Rapp, Marion;
    • Sabel, Michael;
    • Herrlinger, Ulrich;
    • Heinzel, Alexander;
    • Schäfer, Niklas;
    • Ruge, Maximilian;
    • Goldbrunner, Roland;
    • Stoffels, Gabriele;
    • Kabbasch, Christoph;
    • Fink, Gereon R.;
    • Langen, Karl-Josef;
    • Galldiks, Norbert
    Publication type:
    Article
    28

    Early treatment response assessment using <sup>18</sup>F-FET PET compared to contrast-enhanced MRI in glioma patients following adjuvant temozolomide chemotherapy.

    Published in:
    Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.254243
    By:
    • Ceccon, Garry;
    • Lohmann, Philipp;
    • Werner, Jan-Michael;
    • Tscherpel, Caroline;
    • Dunkl, Veronika;
    • Stoffels, Gabriele;
    • Rosen, Jurij;
    • Rapp, Marion;
    • Sabel, Michael;
    • Herrlinger, Ulrich;
    • Schäfer, Niklas;
    • Shah, Nadim J.;
    • Fink, Gereon R.;
    • Langen, Karl-Josef;
    • Galldiks, Norbert
    Publication type:
    Article
    29

    Early treatment response assessment using <sup>18</sup>F-FET PET compared to contrast-enhanced MRI in glioma patients following adjuvant temozolomide chemotherapy.

    Published in:
    Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.254243
    By:
    • Ceccon, Garry;
    • Lohmann, Philipp;
    • Werner, Jan-Michael;
    • Tscherpel, Caroline;
    • Dunkl, Veronika;
    • Stoffels, Gabriele;
    • Rosen, Jurij;
    • Rapp, Marion;
    • Sabel, Michael;
    • Herrlinger, Ulrich;
    • Schäfer, Niklas;
    • Shah, Nadim J.;
    • Fink, Gereon R.;
    • Langen, Karl-Josef;
    • Galldiks, Norbert
    Publication type:
    Article
    30

    Correction to: Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses.

    Published in:
    2023
    By:
    • Zeyen, Thomas;
    • Paech, Daniel;
    • Weller, Johannes;
    • Schäfer, Niklas;
    • Tzaridis, Theophilos;
    • Duffy, Cathrina;
    • Nitsch, Louisa;
    • Schneider, Matthias;
    • Potthoff, Anna-Laura;
    • Steinbach, Joachim Peter;
    • Hau, Peter;
    • Schlegel, Uwe;
    • Seidel, Clemens;
    • Krex, Dietmar;
    • Grauer, Oliver;
    • Goldbrunner, Roland;
    • Zeiner, Pia Susan;
    • Tabatabai, Ghazaleh;
    • Galldiks, Norbert;
    • Stummer, Walter
    Publication type:
    Correction Notice
    31

    The proneural subtype is not associated with survival benefit from bevacizumab in newly diagnosed glioblastoma: a secondary analysis of the GLARIUS trial.

    Published in:
    Journal of Neuro-Oncology, 2023, v. 164, n. 3, p. 749, doi. 10.1007/s11060-023-04470-9
    By:
    • Weller, Johannes;
    • Zeyen, Thomas;
    • Schäfer, Niklas;
    • Schaub, Christina;
    • Potthoff, Anna-Laura;
    • Steinbach, Joachim P.;
    • Hau, Peter;
    • Seidel, Clemens;
    • Goldbrunner, Roland;
    • Tabatabai, Ghazaleh;
    • Vatter, Hartmut;
    • Tzaridis, Theophilos;
    • Schneider, Matthias;
    • Herrlinger, Ulrich
    Publication type:
    Article
    32

    Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses.

    Published in:
    Journal of Neuro-Oncology, 2023, v. 164, n. 3, p. 607, doi. 10.1007/s11060-023-04444-x
    By:
    • Zeyen, Thomas;
    • Paech, Daniel;
    • Weller, Johannes;
    • Schäfer, Niklas;
    • Tzaridis, Theophilos;
    • Duffy, Cathrina;
    • Nitsch, Louisa;
    • Schneider, Matthias;
    • Potthoff, Anna-Laura;
    • Steinbach, Joachim Peter;
    • Hau, Peter;
    • Schlegel, Uwe;
    • Seidel, Clemens;
    • Krex, Dietmar;
    • Grauer, Oliver;
    • Goldbrunner, Roland;
    • Zeiner, Pia Susan;
    • Tabatabai, Ghazaleh;
    • Galldiks, Norbert;
    • Stummer, Walter
    Publication type:
    Article
    33

    Outcome assessment of intraoperative radiotherapy for brain metastases: results of a prospective observational study with comparative matched-pair analysis.

    Published in:
    Journal of Neuro-Oncology, 2023, v. 164, n. 1, p. 107, doi. 10.1007/s11060-023-04380-w
    By:
    • Layer, Julian P.;
    • Hamed, Motaz;
    • Potthoff, Anna-Laura;
    • Dejonckheere, Cas S.;
    • Layer, Katharina;
    • Sarria, Gustavo R.;
    • Scafa, Davide;
    • Koch, David;
    • Köksal, Mümtaz;
    • Kugel, Fabian;
    • Grimmer, Molina;
    • Holz, Jasmin A.;
    • Zeyen, Thomas;
    • Friker, Lea L.;
    • Borger, Valeri;
    • Schmeel, F. Carsten;
    • Weller, Johannes;
    • Hölzel, Michael;
    • Schäfer, Niklas;
    • Garbe, Stephan
    Publication type:
    Article
    34
    35

    Prognostic impact of obesity in newly-diagnosed glioblastoma: a secondary analysis of CeTeG/NOA-09 and GLARIUS.

    Published in:
    Journal of Neuro-Oncology, 2022, v. 159, n. 1, p. 95, doi. 10.1007/s11060-022-04046-z
    By:
    • Weller, Johannes;
    • Schäfer, Niklas;
    • Schaub, Christina;
    • Potthoff, Anna-Laura;
    • Steinbach, Joachim P.;
    • Schlegel, Uwe;
    • Sabel, Michael;
    • Hau, Peter;
    • Seidel, Clemens;
    • Krex, Dietmar;
    • Goldbrunner, Roland;
    • Pietsch, Torsten;
    • Tzaridis, Theophilos;
    • Zeyen, Thomas;
    • Borger, Valeri;
    • Güresir, Erdem;
    • Vatter, Hartmut;
    • Herrlinger, Ulrich;
    • Schneider, Matthias
    Publication type:
    Article
    36
    37

    Implementation, relevance, and virtual adaptation of neuro-oncological tumor boards during the COVID-19 pandemic: a nationwide provider survey.

    Published in:
    Journal of Neuro-Oncology, 2021, v. 153, n. 3, p. 479, doi. 10.1007/s11060-021-03784-w
    By:
    • Schäfer, Niklas;
    • Bumes, Elisabeth;
    • Eberle, Fabian;
    • Fox, Viola;
    • Gessler, Florian;
    • Giordano, Frank A.;
    • Konczalla, Juergen;
    • Onken, Julia;
    • Ottenhausen, Malte;
    • Scherer, Moritz;
    • Schneider, Matthias;
    • Vatter, Hartmut;
    • Herrlinger, Ulrich;
    • Schuss, Patrick
    Publication type:
    Article
    38
    39

    Machine learning-based differentiation between multiple sclerosis and glioma WHO II°-IV° using O-(2-[18F] fluoroethyl)-L-tyrosine positron emission tomography.

    Published in:
    Journal of Neuro-Oncology, 2021, v. 152, n. 2, p. 325, doi. 10.1007/s11060-021-03701-1
    By:
    • Kebir, Sied;
    • Rauschenbach, Laurèl;
    • Weber, Manuel;
    • Lazaridis, Lazaros;
    • Schmidt, Teresa;
    • Keyvani, Kathy;
    • Schäfer, Niklas;
    • Milia, Asma;
    • Umutlu, Lale;
    • Pierscianek, Daniela;
    • Stuschke, Martin;
    • Forsting, Michael;
    • Sure, Ulrich;
    • Kleinschnitz, Christoph;
    • Antoch, Gerald;
    • Colletti, Patrick M.;
    • Rubello, Domenico;
    • Herrmann, Ken;
    • Herrlinger, Ulrich;
    • Scheffler, Björn
    Publication type:
    Article
    40
    41
    42

    Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial.

    Published in:
    Journal of Neuro-Oncology, 2019, v. 144, n. 3, p. 501, doi. 10.1007/s11060-019-03246-4
    By:
    • Kebir, Sied;
    • Schaub, Christina;
    • Junold, Nina;
    • Hattingen, Elke;
    • Schäfer, Niklas;
    • Steinbach, Joachim P.;
    • Weyerbrock, Astrid;
    • Hau, Peter;
    • Goldbrunner, Roland;
    • Galldiks, Norbert;
    • Weller, Johannes;
    • Mack, Frederic;
    • Tzaridis, Theophilos;
    • Bähr, Oliver;
    • Seidel, Clemens;
    • Schlegel, Uwe;
    • Schmidt-Graf, Friederike;
    • Rohde, Veit;
    • Borchers, Christian;
    • Tabatabai, Ghazaleh
    Publication type:
    Article
    43

    Prognostic factors in recurrent glioblastoma patients treated with bevacizumab.

    Published in:
    Journal of Neuro-Oncology, 2016, v. 129, n. 1, p. 93, doi. 10.1007/s11060-016-2144-7
    By:
    • Schaub, Christina;
    • Tichy, Julia;
    • Schäfer, Niklas;
    • Franz, Kea;
    • Mack, Frederic;
    • Mittelbronn, Michel;
    • Kebir, Sied;
    • Thiepold, Anna-Luisa;
    • Waha, Andreas;
    • Filmann, Natalie;
    • Banat, Mohammed;
    • Fimmers, Rolf;
    • Steinbach, Joachim;
    • Herrlinger, Ulrich;
    • Rieger, Johannes;
    • Glas, Martin;
    • Bähr, Oliver
    Publication type:
    Article
    44
    45

    Benchmarking Safety Indicators of Surgical Treatment of Brain Metastases Combined with Intraoperative Radiotherapy: Results of Prospective Observational Study with Comparative Matched-Pair Analysis.

    Published in:
    Cancers, 2022, v. 14, n. 6, p. 1515, doi. 10.3390/cancers14061515
    By:
    • Hamed, Motaz;
    • Potthoff, Anna-Laura;
    • Layer, Julian P.;
    • Koch, David;
    • Borger, Valeri;
    • Heimann, Muriel;
    • Scafa, Davide;
    • Sarria, Gustavo R.;
    • Holz, Jasmin A.;
    • Schmeel, Frederic Carsten;
    • Radbruch, Alexander;
    • Güresir, Erdem;
    • Schäfer, Niklas;
    • Schuss, Patrick;
    • Garbe, Stephan;
    • Giordano, Frank A.;
    • Herrlinger, Ulrich;
    • Vatter, Hartmut;
    • Schmeel, Leonard Christopher;
    • Schneider, Matthias
    Publication type:
    Article
    46

    Combined Assessment of Preoperative Frailty and Sarcopenia Allows the Prediction of Overall Survival in Patients with Lung Cancer (NSCLC) and Surgically Treated Brain Metastasis.

    Published in:
    Cancers, 2021, v. 13, n. 13, p. 3353, doi. 10.3390/cancers13133353
    By:
    • Ilic, Inja;
    • Faron, Anton;
    • Heimann, Muriel;
    • Potthoff, Anna-Laura;
    • Schäfer, Niklas;
    • Bode, Christian;
    • Borger, Valeri;
    • Eichhorn, Lars;
    • Giordano, Frank A.;
    • Güresir, Erdem;
    • Jacobs, Andreas H.;
    • Ko, Yon-Dschun;
    • Landsberg, Jennifer;
    • Lehmann, Felix;
    • Radbruch, Alexander;
    • Herrlinger, Ulrich;
    • Vatter, Hartmut;
    • Schuss, Patrick;
    • Schneider, Matthias
    Publication type:
    Article
    47
    48

    Comorbidity Burden and Presence of Multiple Intracranial Lesions Are Associated with Adverse Events after Surgical Treatment of Patients with Brain Metastases.

    Published in:
    Cancers, 2020, v. 12, n. 11, p. 3209, doi. 10.3390/cancers12113209
    By:
    • Schneider, Matthias;
    • Heimann, Muriel;
    • Schaub, Christina;
    • Eichhorn, Lars;
    • Potthoff, Anna-Laura;
    • Giordano, Frank A.;
    • Güresir, Erdem;
    • Ko, Yon-Dschun;
    • Landsberg, Jennifer;
    • Lehmann, Felix;
    • Radbruch, Alexander;
    • Schwab, Katjana S.;
    • Weinhold, Leonie;
    • Weller, Johannes;
    • Wispel, Christian;
    • Herrlinger, Ulrich;
    • Vatter, Hartmut;
    • Schäfer, Niklas;
    • Schuss, Patrick
    Publication type:
    Article
    49
    50

    Primary CNS lymphoma: a clinician's guide.

    Published in:
    Expert Review of Neurotherapeutics, 2012, v. 12, n. 10, p. 1197, doi. 10.1586/ERN.12.120
    By:
    • Schäfer, Niklas;
    • Glas, Martin;
    • Herrlinger, Ulrich
    Publication type:
    Article